fluorescein has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, D; Gu, Z; Li, S; Love, S; Rivera, KA; Singh, Y; Sinko, PJ; Stein, S | 1 |
| Ritzi, EM | 1 |
| Dagar, S; Onyüksel, H; Rubinstein, I; Sekosan, M | 1 |
3 other study(ies) available for fluorescein and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Influence of molecular size on the retention of polymeric nanocarrier diagnostic agents in breast ducts.
Topics: Animals; Female; Fluorescein; Half-Life; Mammary Neoplasms, Experimental; Nanoparticles; Polyethylene Glycols; Polymers; Rats, Sprague-Dawley | 2012 |
Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Antigens, Viral, Tumor; Dexamethasone; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescein; Fluoresceins; Glucocorticoids; Hydrocortisone; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Receptors, Glucocorticoid; Time Factors; Tumor Cells, Cultured | 1996 |
Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting.
Topics: Alkylating Agents; Animals; Breast Neoplasms; Cell Transformation, Neoplastic; Female; Fluorescein; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Receptors, Vasoactive Intestinal Peptide | 2001 |